Chemoinformaics analysis of 17-Pentatriacontene
Molecular Weight | 490.945 | nRot | 31 |
Heavy Atom Molecular Weight | 420.385 | nRig | 6 |
Exact Molecular Weight | 490.548 | nRing | 0 |
Solubility: LogS | -0.011 | nHRing | 0 |
Solubility: LogP | 1.733 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 105 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 70 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 35 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 105.126 |
nHD | 0 | BPOL | 70.2245 |
QED | 0.617 |
Synth | 2.494 |
Natural Product Likeliness | -0.877 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.005 |
HIA | 0.004 |
CACO-2 | -4.487 |
MDCK | 0.0000307 |
BBB | 0.816 |
PPB | 0.388985 |
VDSS | 1.671 |
FU | 0.55464 |
CYP1A2-inh | 0.9 |
CYP1A2-sub | 0.776 |
CYP2c19-inh | 0.132 |
CYP2c19-sub | 0.578 |
CYP2c9-inh | 0.074 |
CYP2c9-sub | 0.279 |
CYP2d6-inh | 0.022 |
CYP2d6-sub | 0.343 |
CYP3a4-inh | 0.213 |
CYP3a4-sub | 0.432 |
CL | 10.795 |
T12 | 0.731 |
hERG | 0.031 |
Ames | 0.004 |
ROA | 0.223 |
SkinSen | 0.913 |
Carcinogencity | 0.17 |
EI | 0.74 |
Respiratory | 0.799 |
NR-Aromatase | 0.036 |
Antiviral | No |
Prediction | 0.575843 |